{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:22Z","timestamp":1787010022882,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To report the successful treatment of 3 cases of recalcitrant fungal keratitis (FK) with high-dose oral posaconazole.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This is a series of 3 patients from a single academic center with a culture-positive FK who were treated with oral posaconazole after failing to respond to conventional treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      All 3 patients had a history of contact lens wear. Two of the 3 cases were culture positive for\n                      <jats:italic toggle=\"yes\">Fusarium<\/jats:italic>\n                      and the other for\n                      <jats:italic toggle=\"yes\">Paecilomyces<\/jats:italic>\n                      . The infections of all 3 failed to respond to conventional antifungal therapies including varying combinations of topical, systemic, and intraocular antifungal therapies. All 3 cases rapidly responded to high-dose oral posaconazole ranging from 500 to 600 mg once daily. In 1 case, multiple courses of high-dose therapy were required to treat delayed recurrences of a latent infection. There were no significant adverse effects with the elevated dose, and treatment was administered with the guidance of an infectious disease specialist.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In cases of recalcitrant FK failing to respond to conventional therapies, high-dose posaconazole, in the delayed-release tablet formulation, can be an effective treatment option.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ico.0000000000002832","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T15:03:34Z","timestamp":1630508614000},"page":"852-856","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["High-Dose Oral Posaconazole for the Treatment of Recalcitrant Fungal Keratitis"],"prefix":"10.1097","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7754-0465","authenticated-orcid":false,"given":"Tanner J.","family":"Ferguson","sequence":"first","affiliation":[{"name":"Cole Eye Institute, Cleveland Clinic, Cleveland, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Downes","sequence":"additional","affiliation":[{"name":"Cole Eye Institute, Cleveland Clinic, Cleveland, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos M.","family":"Isada","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease, Cleveland Clinic, Cleveland, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff M.","family":"Goshe","sequence":"additional","affiliation":[{"name":"Cole Eye Institute, Cleveland Clinic, Cleveland, OH; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,30]]},"reference":[{"key":"R1-20250728","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1136\/bjo.2009.169607","article-title":"Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature","volume":"95","author":"Shah","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R2-20250728","first-page":"e49","article-title":"The global incidence and diagnosis of fungal keratitis","volume":"95","author":"Brown","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"R3-20250728","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.ophtha.2010.09.011","article-title":"Clinical and microbiological characteristics of fungal keratitis in the United States, 2001\u20132007: a multicenter study","volume":"118","author":"Keay","year":"2011","journal-title":"Ophthalmology"},{"key":"R4-20250728","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1590\/S0034-72802013000200014","article-title":"Antifungals in eye infections: drugs and routes of administration","volume":"72","author":"M\u00fcller","year":"2013","journal-title":"Revista Brasileira de Oftalmologia"},{"key":"R5-20250728","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/ICO.0000000000001781","article-title":"Management algorithm for fungal keratitis: the TST (topical, systemic, and targeted therapy) protocol","volume":"38","author":"Sharma","year":"2019","journal-title":"Cornea"},{"key":"R6-20250728","first-page":"597","article-title":"Natamycin in the treatment of fungal keratitis: a systematic review and meta-analysis","volume":"8","author":"Qiu","year":"2015","journal-title":"Int J Ophthalmol"},{"key":"R7-20250728","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1001\/jamaophthalmol.2013.1497","article-title":"The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole","volume":"131","author":"Prajna","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R8-20250728","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/sj.eye.6700557","article-title":"Fungal infections of the cornea","volume":"17","author":"Thomas","year":"2003","journal-title":"Eye (Lond)"},{"key":"R9-20250728","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/ICO.0000000000001365","article-title":"Comparison of oral voriconazole versus oral ketoconazole as an adjunct to topical natamycin in severe fungal keratitis: a randomized controlled trial","volume":"36","author":"Sharma","year":"2017","journal-title":"Cornea"},{"key":"R10-20250728","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajo.2006.10.048","article-title":"Successful treatment of resistant ocular fusariosis with posaconazole (SCH-56592)","volume":"143","author":"Tu","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"R11-20250728","first-page":"701653","article-title":"Effectiveness of posaconazole in recalcitrant fungal keratitis resistant to conventional antifungal drugs","volume":"2014","author":"Altun","year":"2014","journal-title":"Case Rep Ophthalmol Med"},{"key":"R12-20250728","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/myc.13028","article-title":"High\u2010dose posaconazole for azole\u2010resistant aspergillosis and other difficult\u2010to\u2010treat mould infections","volume":"63","author":"Schauwvlieghe","year":"2020","journal-title":"Mycoses"},{"key":"R13-20250728","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/ICO.0000000000000143","article-title":"Successful treatment of Paecilomyces lilacinus keratitis with oral posaconazole","volume":"33","author":"Arnoldner","year":"2014","journal-title":"Cornea"},{"key":"R14-20250728","doi-asserted-by":"crossref","first-page":"e228645","DOI":"10.1136\/bcr-2018-228645","article-title":"Posaconazole in the treatment of refractory Purpureocillium lilacinum (former Paecilomyces lilacinus) keratitis: the salvation when nothing works","volume":"12","author":"Oliveira","year":"2019","journal-title":"BMJ Case Rep CP"},{"key":"R15-20250728","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.86.7.829-a","article-title":"Ocular and systemic posaconazole (SCH-56592) treatment of invasive Fusarium solani keratitis and endophthalmitis","volume":"86","author":"Sponsel","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R16-20250728","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/jac\/dkv380","article-title":"Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease","volume":"71","author":"Cornely","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"R17-20250728","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s40265-020-01306-y","article-title":"Pharmacokinetics and pharmacodynamics of posaconazole","volume":"80","author":"Chen","year":"2020","journal-title":"Drugs"},{"key":"R18-20250728","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/myc.12326","article-title":"Serum posaconazole levels during acute myeloid leukaemia induction therapy: correlations with breakthrough invasive fungal infections","volume":"58","author":"Cattaneo","year":"2015","journal-title":"Mycoses"},{"key":"R19-20250728","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2710.2009.01055.x","article-title":"Tolerability and safety profile of posaconazole: evaluation of 18 controlled studies in healthy volunteers","volume":"34","author":"Moton","year":"2009","journal-title":"J Clin Pharm Ther"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002832","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T22:04:59Z","timestamp":1753740299000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000002832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,30]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000002832","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,30]]},"assertion":[{"value":"2021-03-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-04","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}